238 related articles for article (PubMed ID: 30567415)
1. Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives.
Arbitrio M; Di Martino MT; Scionti F; Barbieri V; Pensabene L; Tagliaferri P
High Throughput; 2018 Dec; 7(4):. PubMed ID: 30567415
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice.
Arbitrio M; Scionti F; Di Martino MT; Caracciolo D; Pensabene L; Tassone P; Tagliaferri P
Clin Transl Sci; 2021 Jan; 14(1):113-119. PubMed ID: 33089968
[TBL] [Abstract][Full Text] [Related]
3. DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.
Arbitrio M; Di Martino MT; Scionti F; Agapito G; Guzzi PH; Cannataro M; Tassone P; Tagliaferri P
Oncotarget; 2016 Aug; 7(33):54028-54050. PubMed ID: 27304055
[TBL] [Abstract][Full Text] [Related]
4. Tools in Pharmacogenomics Biomarker Identification for Cancer Patients.
Scionti F; Di Martino MT; Caracciolo D; Pensabene L; Tagliaferri P; Arbitrio M
Methods Mol Biol; 2022; 2401():1-12. PubMed ID: 34902118
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics of soft tissue sarcomas: New horizons to understand efficacy and toxicity.
Gambale E; Boddi A; Pasqui A; Campanacci DA; Scoccianti G; Palchetti I; Bernini A; Antonuzzo L; Pillozzi S
Cancer Treat Res Commun; 2022; 31():100528. PubMed ID: 35123198
[TBL] [Abstract][Full Text] [Related]
6. Update on next generation sequencing of pharmacokinetics-related genes: Development of the PKseq panel, a platform for amplicon sequencing of drug-metabolizing enzyme and drug transporter genes.
Fukunaga K; Momozawa Y; Mushiroda T
Drug Metab Pharmacokinet; 2021 Apr; 37():100370. PubMed ID: 33508759
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments.
Lauschke VM; Milani L; Ingelman-Sundberg M
AAPS J; 2017 Nov; 20(1):4. PubMed ID: 29181807
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy.
Li J; Bluth MH
Pharmgenomics Pers Med; 2011; 4():11-33. PubMed ID: 23226051
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics and Personalized Medicine.
Cecchin E; Stocco G
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic and pharmacogenomic discovery strategies.
Crisafulli C; Romeo PD; Calabrò M; Epasto LM; Alberti S
Cancer Drug Resist; 2019; 2(2):225-241. PubMed ID: 35582724
[TBL] [Abstract][Full Text] [Related]
11. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.
Cecchin E; De Mattia E; Ecca F; Toffoli G
Drug Resist Updat; 2018 Jul; 39():18-40. PubMed ID: 30075835
[TBL] [Abstract][Full Text] [Related]
12. Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing.
Silgado-Guzmán DF; Angulo-Aguado M; Morel A; Niño-Orrego MJ; Ruiz-Torres DA; Contreras Bravo NC; Restrepo CM; Ortega-Recalde O; Fonseca-Mendoza DJ
Front Pharmacol; 2022; 13():931531. PubMed ID: 35846994
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics in the era of next generation sequencing - from byte to bedside.
Russell LE; Zhou Y; Almousa AA; Sodhi JK; Nwabufo CK; Lauschke VM
Drug Metab Rev; 2021 May; 53(2):253-278. PubMed ID: 33820459
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics: Driving Personalized Medicine.
Sadee W; Wang D; Hartmann K; Toland AE
Pharmacol Rev; 2023 Jul; 75(4):789-814. PubMed ID: 36927888
[TBL] [Abstract][Full Text] [Related]
15. Students' knowledge and views on pharmacogenomic education in the medical curriculum.
Agrawal M; Kirtania L; Jha A; Hishikar R
Indian J Pharmacol; 2021; 53(1):19-24. PubMed ID: 33975995
[TBL] [Abstract][Full Text] [Related]
16. The Prevalence of Pharmacogenomics Variants and Their Clinical Relevance Among the Pakistani Population.
Khan AR; Shah SH; Ajaz S; Firasat S; Abid A; Raza A
Evol Bioinform Online; 2022; 18():11769343221095834. PubMed ID: 35497687
[TBL] [Abstract][Full Text] [Related]
17. Integrating rare genetic variants into pharmacogenetic drug response predictions.
Ingelman-Sundberg M; Mkrtchian S; Zhou Y; Lauschke VM
Hum Genomics; 2018 May; 12(1):26. PubMed ID: 29793534
[TBL] [Abstract][Full Text] [Related]
18. How to Consider Rare Genetic Variants in Personalized Drug Therapy.
Lauschke VM; Ingelman-Sundberg M
Clin Pharmacol Ther; 2018 May; 103(5):745-748. PubMed ID: 29313952
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics of chemotherapeutic susceptibility and toxicity.
Moen EL; Godley LA; Zhang W; Dolan ME
Genome Med; 2012; 4(11):90. PubMed ID: 23199206
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomic biomarkers for personalized cancer treatment.
Rodríguez-Antona C; Taron M
J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
